Market Currents
Covidien (COV) gets FDA approval for its Solitaire FR revascularization device, which will be...
-
Monday, March 5, 2012, 7:26 AM ETCovidien (COV) gets FDA approval for its Solitaire FR revascularization device, which will be available in the U.S. starting next month. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
